CJC-1295 NO DAC 5mg + Ipa 5mg 10mg

This product comprises CJC-1295 (Non-Acetylated) with N,N-Diethylacetamide (NO DAC) and Ipamoren (Ipa). These peptides are designed for research purposes only, providing valuable tools to study growth hormone secretion and related biological processes.

Research Context

CJC-1295 is a non-acetylated version of the hexapeptide CJC-1295, which acts as an analog of the natural human growth hormone-releasing hormone (GHRH). It has been extensively used in research to investigate its effects on growth hormone levels and associated physiological responses. NO DAC is a solubilizing agent that enhances the stability and bioavailability of peptides during storage and administration. Ipa, also known as N-Acetyl-2,3-Diaminopropionic acid, is another compound that has been explored for its potential to modulate growth hormone secretion.

Research Overview

The combination of CJC-1295 with NO DAC and Ipa allows researchers to explore a range of biological mechanisms involved in growth hormone regulation. These peptides can be utilized in various experimental setups, from cell culture studies to animal models, to understand the complex interactions between GHRH analogs and their receptors.

Key Research Focus Areas

• Evaluation of CJC-1295’s impact on growth hormone levels and secretion mechanisms
• Investigation into NO DAC’s role in enhancing peptide stability and bioavailability
• Analysis of Ipa’s influence on growth hormone dynamics in different cellular environments
• Characterization of the synergistic effects between CJC-1295, NO DAC, and Ipa

Final Compliance Disclaimer

This product is intended for research use only. Not for human or animal consumption.